Kabra Drugs Ltd — Important, 13-10-2025: Company Update

Kabra Drugs Limited's Registrar and Share Transfer Agent, Skyline Financial Services, has confirmed compliance with SEBI regulations for the quarter ended September 30, 2025. The certificate states that physical share certificates received for dematerialization were duly listed on the stock exchange, then verified, mutilated, and cancelled. The depository's name was subsequently recorded as the new registered owner in company records within 15 days. This highlights the company's adherence to regulatory requirements for processing share dematerialization, ensuring accurate and transparent record-keeping for shareholders.